Adeptrix
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
100 Cummings Ctr Ste 438Q, Beverly, Mass...Phone Number
(617) 302-6669Website
www.adeptrix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Adeptrix
Adeptrix Corp. is a bioanalytical company based in Beverly, MA, specializing in high-resolution immunoassay technology known as Bead Assisted Mass Spectrometry (BAMS) for rapid molecular fingerprinting of biological particles. Their innovative solutions are designed for biomarker discovery and custom assay development, particularly for origin-specific liquid biopsies and biomanufacturing. Adeptrix serves various industries, including oncology, autoimmune diseases, neurodegenerative diseases, and metabolic diseases, providing insights into complex biological systems. The company aims to bridge the gap between solid and liquid biopsies, facilitating the analysis of extracellular vesicles and other biological targets.Explore more
Adeptrix Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Adeptrix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Adeptrix has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Adeptrix
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Adeptrix had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Adeptrix, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Adeptrix is spiking on competitors!
Product Launch: Get notified when Adeptrix launches new products
Funding: Get notified immidiatlly once Adeptrix has new funding data
Earning: See what the market has to say on Adeptrix recently announced quarterly report
Recommended Actions
Find VP level buyers at Adeptrix
Find 3 more new buyers
Compare Similar Companies to Adeptrix
Compare insights from companies similar to Adeptrix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Adeptrix is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Adeptrix is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Adeptrix.
Adeptrix Tech Stack
A closer look at the technologies used by Adeptrix
See more technologies
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Funding
Partnership
Research & Development, Clinical Systems
Partnership
Adeptrix News & Media
Avacta Announces Collaboration Agreement With Bruker
CAMBRIDGE & WETHERBY, England & BILLERICA, Mass.--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, announces that it has entered into a collaboration agreement with Bruker Corporation (Billerica, MA) (NASDAQ: BRKR, “Bruker”) to evaluate the Affimer-based, bead assisted mass spectrometry (“BAMS™”) SARS-CoV-2 assay, that the Group has developed with Adeptrix Inc. (Beverley, MA) (“Adeptrix”). Bruker is one of the world’s leading analytical instAdeptrix Closes Series A Financing to Commercialize BAMS™ Bioanalytical Reagents for Life Science Research
BEVERLY, Mass.--(BUSINESS WIRE)-- #Adeptrix--The funding will be used for commercializing multiple BAMS products and establishing assay development services for pharma and clinical customersAvacta Launches SARS-CoV-2 BAMS Research Test
WETHERBY, England & CAMBRIDGE, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce that the BAMS™ assay to detect the SARS-CoV-2 virus has been launched as a research kit1 by its partner Adeptrix (Beverly, MA, USA) and the assay has been presented by Bruker Scientific (Billerica, MA, USA), a leading mass spectrometer manufacturer, in a new applicat
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Adeptrix
Sign Up For FreeTo access detailed company insights
Adeptrix Corp. is a bioanalytical company based in Beverly, MA, specializing in high-resolution immunoassay technology known as Bead Assisted Mass Spectrometry (BAMS) for rapid molecular fingerprinting of biological particles. Their innovative solutions are designed for biomarker discovery and custom assay development, particularly for origin-speci... Read More
